VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $8,208,000 | -62.0% | 41,324 | -72.6% | 0.12% | -60.3% |
| Q4 2014 | $21,617,000 | -5.7% | 151,056 | -13.6% | 0.32% | -8.2% |
| Q3 2014 | $22,932,000 | +6.3% | 174,793 | +2.2% | 0.34% | +11.7% |
| Q2 2014 | $21,569,000 | -66.3% | 171,028 | -64.8% | 0.31% | -68.2% |
| Q1 2014 | $64,053,000 | -24.8% | 485,881 | -33.0% | 0.96% | -27.3% |
| Q4 2013 | $85,135,000 | +12.1% | 725,173 | -0.3% | 1.33% | +3.7% |
| Q3 2013 | $75,917,000 | +20.7% | 727,666 | -0.4% | 1.28% | +7.5% |
| Q2 2013 | $62,914,000 | – | 730,878 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |